drugset / Trial / NCT01742611
Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
NaSingle-groupOpen-labelTreatment
Summary
This is a multi-center, open-labeled, non-comparative study to examine the safety and efficacy of ASP1585 for long-term dosing in chronic kidney disease patients with hyperphosphatemia not on dialysis.
Timeline
- Start
- 2013-03
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bixalomer | Small molecule | — | Oral |